KIT expression and methylation in medulloblastoma and PNET cell lines and tumors

Journal of Neuro-Oncology

Volumn 103, Issue 2, 2011, Pages 247-253

  Enguita Germán, Mónica ^a   Gurrea, Mikel ^a,b   Schiapparelli, Paula ^a   Zhu, Thant S ^b   Crowley, Jessica G ^b   Hamm, Lisa L ^b   Costello, Mark A ^b   He, Xiaobing ^b   Talsma, Caroline E ^b   Flack, Callie G ^b   Hervey Jumper, Shawn L ^b   Heth, Jason A ^b   Muraszko, Karin M ^b   Rey, Juan A ^c   Fan, Xing ^b   Castresana, Javier S ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

KIT; Medulloblastoma; Methylation; PNET; Stem cell factor

Indexed keywords

ARTICLE; CANCER MORPHOLOGY; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; EWING SARCOMA; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MEDULLOBLASTOMA; NEUROECTODERM TUMOR; ONCOGENE C KIT; PROTEIN SYNTHESIS INHIBITION; RHABDOMYOSARCOMA; TUMOR CELL LINE; UPREGULATION;

BLOTTING, WESTERN; CELL LINE, TUMOR; CEREBELLAR NEOPLASMS; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEDULLOBLASTOMA; NERVE SHEATH NEOPLASMS; PROTO-ONCOGENE PROTEINS C-KIT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 79959820058     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0391-6     Document Type: Article

References (20)

1. Smithey BE, Pappo AS, Hill DA (2002) C-kit expression in pediatric solid tumors: a comparative immunohistochemical study. Am J Surg Pathol 26:486-492 (Pubitemid 34280122)
2. Zwerner JP, May WA (2001) PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors. Oncogene 20:626-633 (Pubitemid 32156187)
3. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109 (Pubitemid 47103521)
4. Kleihues P, Sobin LH (2000) World Health Organization classification of tumors. Cancer 88:2887
5. Provias JP, Becker LE (1996) Cellular and molecular pathology of medulloblastoma. J Neurooncol 29:35-43 (Pubitemid 26193502)
6. Biegel JA, Pollack IF (2004) Molecular analysis of pediatric brain tumors. Curr Oncol Rep 6:445-452 (Pubitemid 39585690)
7. Bar EE, Stearns D (2008) New developments in medulloblastoma treatment: the potential of a cyclopamine-lovastatin combination. Expert Opin Investig Drugs 17:185-195 (Pubitemid 351578199)
8. Marino S (2005) Medulloblastoma: developmental mechanisms out of control. Trends Mol Med 11:17-22
9. Reddy AT, Janss AJ, Phillips PC, Weiss HL, Packer RJ (2000) Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy. Cancer 88:2189-2193 (Pubitemid 30233223)
10. Fan X, Eberhart CG (2008) Medulloblastoma stem cells. J Clin Oncol 26:2821-2827
11. Fan X, Matsui W, Khaki L, Stearns D, Chun J, Li YM, Eberhart CG (2006) Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res 66:7445-7452 (Pubitemid 44289197)
12. Fan X, Mikolaenko I, Elhassan I, Ni X, Wang Y, Ball D, Brat DJ, Perry A, Eberhart CG (2004) Notch1 and notch2 have opposite effects on embryonal brain tumor growth. Cancer Res 64:7787-7793 (Pubitemid 39446911)
13. Li LC, Dahiya R (2002) MethPrimer: designing primers for methylation PCRs. Bioinformatics 18:1427-1431
14. Lorente A, Mueller W, Urdangarin E, Lazcoz P, von Deimling A, Castresana JS (2008) Detection of methylation in promoter sequences by melting curve analysis-based semiquantitative real time PCR. BMC Cancer 8:61
15. Chilton-Macneill S, Ho M, Hawkins C, Gassas A, Zielenska M, Baruchel S (2004) C-kit expression and mutational analysis in medulloblastoma. Pediatr Dev Pathol 7:493-498 (Pubitemid 40385239)
16. McCabe MG, Ichimura K, Liu L, Plant K, Backlund LM, Pearson DM, Collins VP (2006) High-resolution array-based comparative genomic hybridization of medulloblastomas and supratentorial primitive neuroectodermal tumors. J Neuropathol Exp Neurol 65:549-561 (Pubitemid 44288939)
17. Heinrich MC, Griffith DJ, Druker BJ, Wait CL, Ott KA, Zigler AJ (2000) Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor. Blood 96:925-932 (Pubitemid 30618049)
18. Chao J, Budd GT, Chu P, Frankel P, Garcia D, Junqueira M, Loera S, Somlo G, Sato J, Chow WA (2010) Phase II clinical trial of imatinib mesylate in therapy of KIT and/or PDGFRalpha-expressing Ewing sarcoma family of tumors and desmoplastic small round cell tumors. Anticancer Res 30:547-552
19. Yamamoto K, Tojo A, Aoki N, Shibuya M (1993) Characterization of the promoter region of the human c-kit proto-oncogene. Jpn J Cancer Res 84:1136-1144 (Pubitemid 23351005)
20. Vandenbark GR, Chen Y, Friday E, Pavlik K, Anthony B, deCastro C, Kaufman RE (1996) Complex regulation of human c-kit transcription by promoter repressors, activators, and specific myb elements. Cell Growth Differ 7:1383-1392 (Pubitemid 26360687)